Insmed Inc. buy UBS Group AG
Start price
29.05.24
/
50%
€46.00
Target price
29.05.25
€53.59
Performance (%)
47.83%
Price
08.08.24
€63.50
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Insmed Inc. has seen massive gains of 47.83%. This prediction currently runs until 29.05.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -3.788% | -3.788% |
| iShares Core DAX® | 0.393% | -2.618% |
| iShares Nasdaq 100 | 0.394% | -10.309% |
| iShares Nikkei 225® | 1.038% | -8.365% |
| iShares S&P 500 | -0.046% | -4.991% |
Comments by UBS_Group_AG for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at UBS Group AG from $46.00 to $58.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat